Compound
Active substance:
naftifine hydrochloride – 10.0 mg.

Indications
     Fungal infections of smooth skin and skin folds (tinea corporis, tinea inquinalis);
     interdigital mycoses (tinea manum, tinea pedum);
     fungal nail infections (onychomycosis);
     skin candidiasis;
     pityriasis versicolor;
     inflammatory dermatomycosis (with or without itching).
Use during pregnancy and breastfeeding
The use of the drug during pregnancy and breastfeeding is contraindicated (the safety and effectiveness of the drug in this category of patients have not been studied).

Contraindications
Hypersensitivity to naftifine or propylene glycol; pregnancy and breastfeeding (the safety and effectiveness of the drug in this category of patients have not been studied).
Application of the drug to the wound surface is contraindicated.

Carefully
Children's age (experience of clinical use is limited).
Side effects
In some cases, local reactions may be observed: dry skin, skin hyperemia and burning. Side effects are reversible and do not require discontinuation of treatment. If any of the side effects indicated in the instructions worsen, or any other side effects not listed in the instructions are noted, you should immediately inform your doctor.


Storage conditions
At a temperature not exceeding 25 °C in the original packaging (bottle in a cardboard box).
Keep out of the reach of children.

Best before date
2 years.